150 related articles for article (PubMed ID: 10435082)
1. Retrovirally transduced bone marrow stromal cells isolated from a mouse model of human osteogenesis imperfecta (oim) persist in bone and retain the ability to form cartilage and bone after extended passaging.
Oyama M; Tatlock A; Fukuta S; Kavalkovich K; Nishimura K; Johnstone B; Robbins PD; Evans CH; Niyibizi C
Gene Ther; 1999 Mar; 6(3):321-9. PubMed ID: 10435082
[TBL] [Abstract][Full Text] [Related]
2. Effect of rhBMP-2 on the osteogenic potential of bone marrow stromal cells from an osteogenesis imperfecta mouse (oim).
Balk ML; Bray J; Day C; Epperly M; Greenberger J; Evans CH; Niyibizi C
Bone; 1997 Jul; 21(1):7-15. PubMed ID: 9213002
[TBL] [Abstract][Full Text] [Related]
3. Local ex vivo gene therapy with bone marrow stromal cells expressing human BMP4 promotes endosteal bone formation in mice.
Zhang XS; Linkhart TA; Chen ST; Peng H; Wergedal JE; Guttierez GG; Sheng MH; Lau KH; Baylink DJ
J Gene Med; 2004 Jan; 6(1):4-15. PubMed ID: 14716672
[TBL] [Abstract][Full Text] [Related]
4. Distribution of single-cell expanded marrow derived progenitors in a developing mouse model of osteogenesis imperfecta following systemic transplantation.
Li F; Wang X; Niyibizi C
Stem Cells; 2007 Dec; 25(12):3183-93. PubMed ID: 17823236
[TBL] [Abstract][Full Text] [Related]
5. In vivo expression of human growth hormone by genetically modified murine bone marrow stromal cells and its effect on the cells in vitro.
Suzuki K; Oyama M; Faulcon L; Robbins PD; Niyibizi C
Cell Transplant; 2000; 9(3):319-27. PubMed ID: 10972331
[TBL] [Abstract][Full Text] [Related]
6. Progenitors systemically transplanted into neonatal mice localize to areas of active bone formation in vivo: implications of cell therapy for skeletal diseases.
Wang X; Li F; Niyibizi C
Stem Cells; 2006 Aug; 24(8):1869-78. PubMed ID: 16675597
[TBL] [Abstract][Full Text] [Related]
7. Transfer of proalpha2(I) cDNA into cells of a murine model of human Osteogenesis Imperfecta restores synthesis of type I collagen comprised of alpha1(I) and alpha2(I) heterotrimers in vitro and in vivo.
Niyibizi C; Smith P; Mi Z; Phillips CL; Robbins P
J Cell Biochem; 2001 Jun 26-Jul 25; 83(1):84-91. PubMed ID: 11500956
[TBL] [Abstract][Full Text] [Related]
8. Bone formation following transplantation of genetically modified primary bone marrow stromal cells.
Sugiyama O; Orimo H; Suzuki S; Yamashita K; Ito H; Shimada T
J Orthop Res; 2003 Jul; 21(4):630-7. PubMed ID: 12798062
[TBL] [Abstract][Full Text] [Related]
9. Bone induction by BMP-2 transduced stem cells derived from human fat.
Dragoo JL; Choi JY; Lieberman JR; Huang J; Zuk PA; Zhang J; Hedrick MH; Benhaim P
J Orthop Res; 2003 Jul; 21(4):622-9. PubMed ID: 12798061
[TBL] [Abstract][Full Text] [Related]
10. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
[TBL] [Abstract][Full Text] [Related]
11. Bone-directed expression of Col1a1 promoter-driven self-inactivating retroviral vector in bone marrow cells and transgenic mice.
Stover ML; Wang CK; McKinstry MB; Kalajzic I; Gronowicz G; Clark SH; Rowe DW; Lichtler AC
Mol Ther; 2001 Apr; 3(4):543-50. PubMed ID: 11319916
[TBL] [Abstract][Full Text] [Related]
12. Autologous transplantation of retrovirally transduced bone marrow or neonatal blood cells into cats can lead to long-term engraftment in the absence of myeloablation.
Simonaro CM; Haskins ME; Abkowitz JL; Brooks DA; Hopwood JJ; Zhang J; Schuchman EH
Gene Ther; 1999 Jan; 6(1):107-13. PubMed ID: 10341882
[TBL] [Abstract][Full Text] [Related]
13. Enhanced engraftment of EPO-transduced human bone marrow stromal cells transplanted in a 3D matrix in non-conditioned NOD/SCID mice.
Daga A; Muraglia A; Quarto R; Cancedda R; Corte G
Gene Ther; 2002 Jul; 9(14):915-21. PubMed ID: 12085239
[TBL] [Abstract][Full Text] [Related]
14. Gene targeting in stem cells from individuals with osteogenesis imperfecta.
Chamberlain JR; Schwarze U; Wang PR; Hirata RK; Hankenson KD; Pace JM; Underwood RA; Song KM; Sussman M; Byers PH; Russell DW
Science; 2004 Feb; 303(5661):1198-201. PubMed ID: 14976317
[TBL] [Abstract][Full Text] [Related]
15. Rat adipose-derived stromal cells expressing BMP4 induce ectopic bone formation in vitro and in vivo.
Lin L; Fu X; Zhang X; Chen LX; Zhang JY; Yu CL; Ma KT; Zhou CY
Acta Pharmacol Sin; 2006 Dec; 27(12):1608-15. PubMed ID: 17112416
[TBL] [Abstract][Full Text] [Related]
16. Correction of a mineralization defect by overexpression of a wild-type cDNA for COL1A1 in marrow stromal cells (MSCs) from a patient with osteogenesis imperfecta: a strategy for rescuing mutations that produce dominant-negative protein defects.
Pochampally RR; Horwitz EM; DiGirolamo CM; Stokes DS; Prockop DJ
Gene Ther; 2005 Jul; 12(14):1119-25. PubMed ID: 15815702
[TBL] [Abstract][Full Text] [Related]
17. In vivo methotrexate selection of murine hemopoietic cells transduced with a retroviral vector for Gaucher disease.
Havenga M; Valerio D; Hoogerbrugge P; Es H
Gene Ther; 1999 Oct; 6(10):1661-9. PubMed ID: 10516714
[TBL] [Abstract][Full Text] [Related]
18. Osteoprogenitor cells within skeletal muscle.
Bosch P; Musgrave DS; Lee JY; Cummins J; Shuler T; Ghivizzani TC; Evans T; Robbins TD; Huard
J Orthop Res; 2000 Nov; 18(6):933-44. PubMed ID: 11192254
[TBL] [Abstract][Full Text] [Related]
19. Fourier transform infrared imaging spectroscopy (FT-IRIS) of mineralization in bisphosphonate-treated oim/oim mice.
Camacho NP; Carroll P; Raggio CL
Calcif Tissue Int; 2003 May; 72(5):604-9. PubMed ID: 12574874
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene.
Cheng SL; Lou J; Wright NM; Lai CF; Avioli LV; Riew KD
Calcif Tissue Int; 2001 Feb; 68(2):87-94. PubMed ID: 11310352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
